🇺🇸 Heplisav-B Injectable Product, 2-dose regimen in United States

Heplisav-B Injectable Product, 2-dose regimen (Heplisav-B Injectable Product, 2-dose regimen) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Heplisav-B Injectable Product, 2-dose regimen in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Heplisav-B Injectable Product, 2-dose regimen approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Heplisav-B Injectable Product, 2-dose regimen in United States?

Mercy Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.